PhysIQ, Department of Defense, and The Henry M. Jackson Foundation for The Advancement of Military Medicine Partner to Deploy Continuous Remote Monitoring Platform to Study COVID-19
The U.S. Department of Defense and the Henry Jackson Foundation for the Advancement of Military Medicine announced they have selected pinpointIQ, physIQ’s continuous remote monitoring solution, to study and treat COVID-19.
While many life sciences leaders have mitigated the most pressing short-term issues, many questions remain about the longer term strategic implications of this pandemic.
Promptly following the FDA's sanctioned labeling of pinpointIQTM to allow for remote monitoring of patients with COVID-19, physIQ released its set of clinical “rules” representative of clinical deterioration in patients diagnosed with or exposed to COVID-19.
From giving back to the community and supporting frontline health care workers to coming up with novel medical solutions and more, Chicago-based companies have not stepped down in the fight against COVID-19. Rather they are using it as an opportunity to innovate, collaborate, and evolve.